Q2 Earnings Estimate for UTHR Issued By Leerink Partnrs
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Investment analysts at Leerink Partnrs reduced their Q2 2025 earnings per share (EPS) estimates for United Therapeutics in a report released on Thursday, February 27th. Leerink Partnrs analyst R. Ruiz now anticipates that the biotechnology company will earn $6.99 per share for the quarter, down from their […]
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Investment analysts at Leerink Partnrs reduced their Q2 2025 earnings per share (EPS) estimates for United Therapeutics in a report released on Thursday, February 27th. Leerink Partnrs analyst R. Ruiz now anticipates that the biotechnology company will earn $6.99 per share for the quarter, down from their […]
